COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 893: Articles 8921-8930  | Next

SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated individuals
Richardson, S. I., Madzorera, V. S., Spencer, H., Manamela, N. P., van der Mescht, M., Lambson, B. E., Oosthuysen, B., Ayres, F., Makhado, Z., Moyo-Gwete, T., Mzindle, N., Motlou, T., Strydom, A., Mendes, A., Tegally, H., de Beer, Z., de Villiers, T. R., Bodenstein, A., van den Berg, G., Venter, M., de Oliviera, T., Ueckermann, V., Rossouw, T. M., Boswell, M. T., Moore, P. L.
10.1101/2022.02.10.22270789 — Posted: 2022-02-14 Discussion: Onsite
Comprehensive humoral and cellular immune responses to SARS-CoV-2 variants in diverse Chinese populations: A benefit perspective of national vaccination
Li, J., Wu, J., Long, Q., Wu, Y., Hu, X., He, Y., Jiang, M., Li, J., Zhao, L., Yang, S., Chen, X., Wang, M., Zheng, J., Wu, F., Wu, R., Ren, L., Bu, L., Wang, H., Li, K., Fu, L., Zhang, G., Zheng, Y., Gao, Z.
10.1101/2022.02.13.22270896 — Posted: 2022-02-14
POST-ACUTE SEQUELAE AND ADAPTIVE IMMUNE RESPONSES IN PEOPLE LIVING WITH HIV RECOVERING FROM SARS-COV-2 INFECTION
Peluso, M. J., Spinelli, M. A., Deveau, T.-M., Forman, C. A., Munter, S. E., Mathur, S., Tang, A. F., Lu, S., Goldberg, S. A., Arreguin, M. I., Hoh, R., Chen, J. Y., Martinez, E. O., Chenna, A., Winslow, J. W., Petropoulos, C. J., Sette, A., Weiskopf, D., Kumar, N., Lynch, K. L., Hunt, P. W., Durstenfeld, M. S., Hsue, P. Y., Kelly, J. D., Martin, J. N., Glidden, D. V., Gandhi, M., Deeks, S. G., Rutishauser, R. L., Henrich, T. J.
10.1101/2022.02.10.22270471 — Posted: 2022-02-14
FOLIC ACID AND METHOTREXATE USE AND THEIR ASSOCIATION WITH COVID-19 DIAGNOSIS AND MORTALITY: AN ANALYSIS FROM THE UK BIOBANK
Topless, R. K., Green, R., Morgan, S. L., Robinson, P. C., Merriman, T. R., Gaffo, A. L.
10.1101/2022.02.10.22270804 — Posted: 2022-02-14
Risk of severe COVID-19 in patients with inflammatory rheumatic diseases treated with immunosuppressive therapy in Scotland
McKeigue, P. M., Porter, D., Hollick, R. J., Ralston, S. J., McAllister, D. A., Colhoun, H. M.
10.1101/2022.02.13.22270898 — Posted: 2022-02-14
Quantifying political influence on COVID-19 fatality in Brazil
de Almeida, L., Carelli, P., Cavalcanti, N. G., do Nascimento, J. D., Felinto, D.
10.1101/2022.02.09.22270714 — Posted: 2022-02-14
Unpacking COVID-19 and Conspiracy Theories in the UK Black Community
Vandrevala, T., Hendy, J., Hanson, K., Alidu, L., Ala, A.
10.1101/2022.02.12.22270438 — Posted: 2022-02-14
COVID-19 in Japan: insights from the first three months of the epidemic
Imai, N., Gaythorpe, K. A. M., Bhatia, S., Mangal, T. D., Cuomo-Dannenburg, G., Unwin, H. J. T., Jauneikaite, E., Ferguson, N. M.
10.1101/2022.02.10.22270735 — Posted: 2022-02-13
Empirical evidence of transmission over a school-household network for SARS-CoV-2; exploration of transmission pairs stratified by primary and secondary school.
van Iersel, S. C. J. L., Backer, J. A., van Gaalen, R. D., Andeweg, S. P., Munday, J. D., Wallinga, J., RIVM COVID-19 epidemiology and surveillance group, , van Hoek, A. J.
10.1101/2022.02.12.22270851 — Posted: 2022-02-13
Adequacy of serial self-performed SARS-CoV-2 rapid antigen-detection testing for longitudinal mass screening in the workplace
Papenburg, J., Campbell, J. R., Caya, C., Dion, C., Corsini, R., Cheng, M., Menzies, D., Yansouni, C. P.
10.1101/2022.02.10.22270805 — Posted: 2022-02-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).